Kim L. R. Brouwer

16.0k total citations
279 papers, 9.7k citations indexed

About

Kim L. R. Brouwer is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Kim L. R. Brouwer has authored 279 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Oncology, 107 papers in Pediatrics, Perinatology and Child Health and 96 papers in Pharmacology. Recurrent topics in Kim L. R. Brouwer's work include Drug Transport and Resistance Mechanisms (191 papers), Pharmacological Effects and Toxicity Studies (94 papers) and Pharmacogenetics and Drug Metabolism (59 papers). Kim L. R. Brouwer is often cited by papers focused on Drug Transport and Resistance Mechanisms (191 papers), Pharmacological Effects and Toxicity Studies (94 papers) and Pharmacogenetics and Drug Metabolism (59 papers). Kim L. R. Brouwer collaborates with scholars based in United States, Japan and United Kingdom. Kim L. R. Brouwer's co-authors include Gary M. Pollack, Kenneth R. Brouwer, Maciej J. Zamek‐Gliszczynski, Priyamvada Chandra, Brandon Swift, Elaine M. Leslie, Keith Hoffmaster, Edward L. LeCluyse, Kathleen Köck and Kyunghee Yang and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Hepatology.

In The Last Decade

Kim L. R. Brouwer

260 papers receiving 9.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim L. R. Brouwer United States	55	6.0k	3.4k	3.2k	1.5k	1.4k	279	9.7k
Hiroyuki Kusuhara Japan	75	10.6k 1.8×	3.5k 1.0×	5.9k 1.8×	1.5k 1.0×	3.2k 2.2×	322	15.7k
Jashvant D. Unadkat United States	67	5.5k 0.9×	2.7k 0.8×	3.8k 1.2×	1.1k 0.7×	2.2k 1.5×	309	12.5k
Patrick Maurel France	63	3.9k 0.7×	6.6k 1.9×	1.2k 0.4×	1.3k 0.9×	3.3k 2.3×	205	12.8k
Paul B. Watkins United States	73	6.2k 1.0×	11.5k 3.4×	3.2k 1.0×	2.3k 1.5×	3.5k 2.5×	246	19.9k
Richard B. Kim Canada	74	9.1k 1.5×	5.7k 1.7×	4.7k 1.5×	1.5k 1.0×	3.7k 2.6×	243	18.5k
Ulrich M. Zanger Germany	74	6.8k 1.1×	10.1k 2.9×	3.1k 1.0×	1.2k 0.8×	5.1k 3.5×	197	19.8k
Tsuyoshi Yokoi Japan	67	4.8k 0.8×	7.2k 2.1×	1.7k 0.5×	1.0k 0.7×	6.2k 4.3×	369	16.2k
Yurong Lai United States	51	4.5k 0.8×	2.6k 0.7×	2.3k 0.7×	748 0.5×	1.2k 0.8×	153	6.7k
Erin G. Schuetz United States	77	9.7k 1.6×	9.8k 2.9×	4.0k 1.3×	958 0.6×	4.7k 3.3×	198	19.9k
Mikko Niemi Finland	64	6.2k 1.0×	5.5k 1.6×	3.2k 1.0×	1.4k 0.9×	2.5k 1.7×	277	15.2k

Countries citing papers authored by Kim L. R. Brouwer

Since Specialization

Citations

This map shows the geographic impact of Kim L. R. Brouwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim L. R. Brouwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim L. R. Brouwer more than expected).

Fields of papers citing papers by Kim L. R. Brouwer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim L. R. Brouwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim L. R. Brouwer. The network helps show where Kim L. R. Brouwer may publish in the future.

Co-authorship network of co-authors of Kim L. R. Brouwer

This figure shows the co-authorship network connecting the top 25 collaborators of Kim L. R. Brouwer. A scholar is included among the top collaborators of Kim L. R. Brouwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim L. R. Brouwer. Kim L. R. Brouwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murphy, William A., et al.. (2025). Impact of Obesity and MASH on Zonal Hepatocellular Statin Exposure: Pharmacodynamic Insights From a Permeability‐Limited Multicompartment Liver Model. CPT Pharmacometrics & Systems Pharmacology. 15(1). e70138–e70138.

Saran, Chitra & Kim L. R. Brouwer. (2023). Hepatic Bile Acid Transporters and Drug-induced Hepatotoxicity. Toxicologic Pathology. 51(7-8). 405–413. 10 indexed citations

Taskar, Kunal S., Xinning Yang, Sibylle Neuhoff, et al.. (2022). Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective. Clinical Pharmacology & Therapeutics. 112(3). 573–592. 23 indexed citations

Zamek‐Gliszczynski, Maciej J., Mitesh Patel, Xinning Yang, et al.. (2020). Intestinal P‐gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications. Clinical Pharmacology & Therapeutics. 109(1). 55–64. 39 indexed citations

Guo, Cen, Kyunghee Yang, Mingxiang Liao, et al.. (2017). Prediction of Hepatic Efflux Transporter-Mediated Drug Interactions: When Is it Optimal to Measure Intracellular Unbound Fraction of Inhibitors?. Journal of Pharmaceutical Sciences. 106(9). 2401–2406. 5 indexed citations

Watt, Kevin, Michael Cohen‐Wolkowiez, Desiree Bonadonna, et al.. (2017). Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit. Journal of ExtraCorporeal Technology. 49(3). 150–159. 35 indexed citations

Köck, Kathleen, et al.. (2015). Toward Predicting Drug-Induced Liver Injury: Parallel Computational Approaches to Identify Multidrug Resistance Protein 4 and Bile Salt Export Pump Inhibitors. Drug Metabolism and Disposition. 43(5). 725–734. 26 indexed citations

Ferslew, Brian C. & Kim L. R. Brouwer. (2014). Identification of Hepatic Phospholipidosis Inducers in Sandwich-Cultured Rat Hepatocytes, a Physiologically Relevant Model, Reveals Altered Basolateral Uptake and Biliary Excretion of Anionic Probe Substrates. Toxicological Sciences. 139(1). 99–107. 9 indexed citations

Pfeifer, Nathan D., Kyunghee Yang, & Kim L. R. Brouwer. (2013). Hepatic Basolateral Efflux Contributes Significantly to Rosuvastatin Disposition I: Characterization of Basolateral Versus Biliary Clearance Using a Novel Protocol in Sandwich-Cultured Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 347(3). 727–736. 81 indexed citations

10.

Yan, Grace, Miyoung Yoon, Richard R. Tidwell, et al.. (2011). A Semiphysiologically Based Pharmacokinetic Modeling Approach to Predict the Dose-Exposure Relationship of an Antiparasitic Prodrug/Active Metabolite Pair. Drug Metabolism and Disposition. 40(1). 6–17. 18 indexed citations

11.

Claire, Robert L. St., et al.. (2011). Differential Disposition of Chenodeoxycholic Acid versus Taurocholic Acid in Response to Acute Troglitazone Exposure in Rat Hepatocytes. Toxicological Sciences. 120(2). 371–380. 18 indexed citations

12.

Lee, Jin Kyung, Mary F. Paine, & Kim L. R. Brouwer. (2010). Sulindac and Its Metabolites Inhibit Multiple Transport Proteins in Rat and Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 334(2). 410–418. 20 indexed citations

13.

Tian, Xianbin, Brandon Swift, Maciej J. Zamek‐Gliszczynski, et al.. (2008). Impact of Basolateral Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 on the Hepatobiliary Disposition of Fexofenadine in Perfused Mouse Livers. Drug Metabolism and Disposition. 36(5). 911–915. 34 indexed citations

14.

Nezasa, Ken-ichi, Xianbin Tian, Maciej J. Zamek‐Gliszczynski, et al.. (2006). ALTERED HEPATOBILIARY DISPOSITION OF 5 (AND 6)-CARBOXY-2′,7′-DICHLOROFLUORESCEIN IN Abcg2 (Bcrp1) AND Abcc2 (Mrp2) KNOCKOUT MICE. Drug Metabolism and Disposition. 34(4). 718–723. 41 indexed citations

15.

Zamek‐Gliszczynski, Maciej J., Keith Hoffmaster, Ken-ichi Nezasa, Melanie N. Tallman, & Kim L. R. Brouwer. (2006). Integration of hepatic drug transporters and phase II metabolizing enzymes: Mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. European Journal of Pharmaceutical Sciences. 27(5). 447–486. 195 indexed citations

16.

Turncliff, Ryan Z., et al.. (2006). Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes. Biochemical Pharmacology. 71(10). 1520–1529. 45 indexed citations

17.

Xiong, Hao, Hiroshi Suzuki, Yuichi Sugiyama, et al.. (2002). Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment. Drug Metabolism and Disposition. 30(9). 962–969. 71 indexed citations

18.

Song, Minho, et al.. (2000). Comparison of Zafirlukast (Accolate®) Absorption After Oral and Colonic Administration in Humans. Pharmaceutical Research. 17(2). 154–159. 21 indexed citations

19.

Moore, Katy H. P., Kim L. R. Brouwer, & P. U. Joyner. (1997). Lessons Gained from Distance Delivery of an Applied Pharmacokinetics Course. American Journal of Pharmaceutical Education. 61(3). 310–313. 1 indexed citations

20.

Hughes, Jeffrey A., Anna V. Avrutskaya, Kim L. R. Brouwer, Eric Wickstrom, & R. L. Juliano. (1995). Radiolabeling of Methylphosphonate and Phosphorothioate Oligonucleotides and Evaluation of Their Transport in Everted Rat Jejunum Sacs. Pharmaceutical Research. 12(6). 817–824. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact